Mostrar el registro sencillo del ítem

dc.contributor.author
Fauzia Malik, A.  
dc.contributor.author
Belizan, María  
dc.contributor.author
Gutierrez, Mariana  
dc.contributor.author
Vilajeliu, Alba  
dc.contributor.author
Sanclemente, Lauren N.  
dc.contributor.author
Gonzalez Casanova, Ines  
dc.contributor.author
Jones, Daniel Eduardo  
dc.contributor.author
Omer, Saad  
dc.contributor.author
Maria Ropero, Alba  
dc.contributor.author
Alonso, Juan Pedro  
dc.date.available
2022-09-27T12:39:05Z  
dc.date.issued
2021-07  
dc.identifier.citation
Fauzia Malik, A.; Belizan, María; Gutierrez, Mariana; Vilajeliu, Alba; Sanclemente, Lauren N.; et al.; Pregnant women's perspectives about maternal immunization in Latin America; Elsevier; Vaccine; 39; 7-2021; 44-49  
dc.identifier.issn
0264-410X  
dc.identifier.uri
http://hdl.handle.net/11336/170581  
dc.description.abstract
Background: Maternal immunization rates and vaccine uptake in Latin America vary from country to country. This variability stems from factors related to pregnant women, vaccine recommendations from healthcare providers and the health system. The aim of this paper is to describe women's knowledge and attitudes to maternal immunziation, and barriers to access and vaccination related decision-making processes in Latin American countries. Methods: We conducted focus group discussions (FGD) with pregnant women in five middle-income countries: Argentina, Brazil, Honduras, Mexico and Peru, between July 2016 and July 2018. The FGDs were conducted by trained qualitative researchers in diverse clinics located in the capital cities of these countries. Results: A total of 162 pregnant women participated in the FGDs. In general, participants were aware of the recommendation to receive vaccines during pregnancy but lacked knowledge regarding the diseases prevented by these vaccines. Pregnant women expressed a desire for clearer and more detailed communication on maternal vaccines by their healthcare professionals instead of relying on other sources of information such as the internet. Overall, participants had positive attitudes towards maternal immunization and were open to receiving vaccines in pregnancy based on general trust they have in recommendations made by their healthcare providers. The main obstacles pregnant women said they encounter were mainly centered around their clinical experience: long waiting times, vaccine shortages, and impolite behavior of healthcare providers or clinical staff. Conclusion: Important advances have been made in Latin America to promote maternal immunization. Results from this study show that an important aspect that remains to be addressed, and is crucial in improving vaccine uptake in pregnancy, is women's clinical experience. We recommend pregnant women to be treated as a priority population for providing immunization and related healthcare education. It is imperative to train healthcare providers in health communication so they can effectively communicate with pregnant women regarding maternal vaccines and can fill knowledge gaps that otherwise might be covered by unreliable sources dispensing inaccurate information.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Elsevier  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/  
dc.subject
ACCEPTANCE  
dc.subject
ATTITUDES  
dc.subject
CLINICAL EXPEREINCE  
dc.subject
HEALTH EDUCATION  
dc.subject
LATIN AMERICA  
dc.subject
MATERNAL IMMUNIZATION  
dc.subject
PREGNANT WOMEN  
dc.subject
VACCINE UPTAKE  
dc.subject.classification
Otras Sociología  
dc.subject.classification
Sociología  
dc.subject.classification
CIENCIAS SOCIALES  
dc.title
Pregnant women's perspectives about maternal immunization in Latin America  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2022-09-26T17:45:19Z  
dc.journal.volume
39  
dc.journal.pagination
44-49  
dc.journal.pais
Países Bajos  
dc.journal.ciudad
Amsterdam  
dc.description.fil
Fil: Fauzia Malik, A.. University of Yale. School of Medicine; Estados Unidos  
dc.description.fil
Fil: Belizan, María. Instituto de Efectividad Clínica y Sanitaria; Argentina  
dc.description.fil
Fil: Gutierrez, Mariana. University of Emory; Estados Unidos  
dc.description.fil
Fil: Vilajeliu, Alba. Pan American Health Organization; Estados Unidos  
dc.description.fil
Fil: Sanclemente, Lauren N.. University of Emory; Estados Unidos  
dc.description.fil
Fil: Gonzalez Casanova, Ines. Indiana University; Estados Unidos. University of Emory; Estados Unidos  
dc.description.fil
Fil: Jones, Daniel Eduardo. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.description.fil
Fil: Omer, Saad. University of Yale; Estados Unidos. University of Yale. School of Medicine; Estados Unidos  
dc.description.fil
Fil: Maria Ropero, Alba. Pan American Health Organization; Estados Unidos  
dc.description.fil
Fil: Alonso, Juan Pedro. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto de Efectividad Clínica y Sanitaria; Argentina  
dc.journal.title
Vaccine  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0264410X20311518  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.vaccine.2020.09.009